Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses-Reference-Cited by-同舟云学术

Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses

Published:2020-11 Issue:6 Volume:21 Page:e633-e639
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Paajanen Juuso^ORCID,Laaksonen Sanna,Ilonen Ilkka,Vehmas Tapio,Mäyränpää Mikko I.,Sutinen Eva,Kettunen Eeva^ORCID,Salo Jarmo A.,Räsänen Jari,Wolff Henrik,Myllärniemi Marjukka

Funder

Helsinki University Hospital

Finnish Medical Foundation

Foundation of the Finnish Anti-Tuberculosis Association

Finnish Cancer Foundation

Finnish Work Environment Fund

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. Biomarkers and prognostic factors for mesothelioma;Pass;Ann Cardiothorac Surg,2012

2. A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma;Kadota;Mod Pathol,2012

3. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival;Baumann;Carcinogenesis,2015

4. Circulating epigenetic biomarkers in lung malignancies: from early diagnosis to therapy;Tomasetti;Lung Cancer,2017

5. Malignant pleural mesothelioma: current and future perspectives;Porpodis;J Thorac Dis,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma;Cancers;2023-03-30

2. A Case of Malignant Pleural Mesothelioma Recurring 10 Years After a Long-term Response to Chemotherapy;Haigan;2023-02-20

3. Contemporary issues in the surgical management of pleural mesothelioma;Journal of Surgical Oncology;2023-01-11

4. Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens;Thoracic Cancer;2023-01-04

5. The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma;International Journal of Molecular Sciences;2022-11-03